Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control
NCT05088876Phase 4Terminated
- Sponsor
- Insel Gruppe
- Start
- Aug 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetaminophen in cancer pain, sponsored by Insel Gruppe. Started Aug 2024; status: terminated.
02
Drugs
acetaminophen
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT05088876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05088876.